Home » Nihon Nohyaku Obtains Manufacturing Approval for Luliconazole
Nihon Nohyaku Obtains Manufacturing Approval for Luliconazole
Nihon Nohyaku announced that it has received approval to manufacture luliconazole-based
angifungal agents, Lulicon Cream 1 percent and Lulicon Solution 1 percent, from
the Ministry of Health, Labor and Welfare as of April 11. Luliconazole, which
is discovered by Nihon Nohyaku in the search of imidazole compounds, is an antifungal
agent with an optical activity.
Japan
Corporate News Network
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct